Hykes Kevin 4

What Happened

• Kevin Hykes, President, CEO and a director of CVRx, sold 7,763 shares of CVRx common stock on March 2, 2026 for a weighted average price of $7.90 (total proceeds about $61,349). The sale was a sell-to-cover transaction to satisfy tax withholding obligations.
• On February 27, 2026 Hykes was granted two restricted stock unit (RSU) awards: 159,000 RSUs (F1) and 238,000 RSUs (reported as a derivative award). The awards have multi-year vesting schedules (see Key Details). These are grants/awards (not open-market purchases).

Key Details

• Filing: Form 4 filed with the SEC on March 3, 2026 (Period of Report: Feb 27, 2026).
• Sale: March 2, 2026 — 7,763 shares sold, weighted avg price $7.90; sale price range $7.90–$8.00 per share (total ≈ $61,349). Reporting person can provide a breakdown of sales by price on request (F3).
• Awards: Feb 27, 2026 — 159,000 RSUs (F1) and 238,000 RSUs (derivative award, F4).
• Vesting notes:
  • F1: 159,000 RSUs vest 25% on each annual anniversary of the grant.
  • F4: 238,000 RSUs vest 25% on Feb 27, 2027, then 1/48th each month thereafter.
• Reason for sale: mandated sell-to-cover to satisfy tax withholding under the award agreement (F2).
• Shares owned after transaction: not specified in the provided summary of the filing.

Context

• The RSU grants are awards that vest over time; they represent future economic ownership if vesting conditions are met, not immediate open-market purchases.
• The March 2 sale was a tax-withholding sell-to-cover (routine and common when executives receive equity awards) rather than an explicit open-market disposition for investment reasons.
• No indication in this filing that the transactions were late; the Form 4 was filed March 3, 2026.

What this means for retail investors: the item to watch is the sizable RSU grants (total 397,000 RSUs) which dilute over time as they vest if issued, while the small sell-to-cover sale is routine and was intended to meet tax obligations, not necessarily a signal about company prospects.